Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Elite Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2002, the company has established itself as a leader in the development and manufacturing of niche generic and branded pharmaceuticals, particularly in the areas of controlled substances and complex formulations.
With a focus on innovative drug delivery systems, Elite Pharmaceuticals offers unique products that cater to unmet medical needs, setting them apart in a competitive market. The company has achieved significant milestones, including partnerships with major pharmaceutical firms and a robust pipeline of products in various stages of development.
Recognised for its commitment to quality and compliance, Elite Pharmaceuticals continues to strengthen its market position, contributing to the advancement of healthcare solutions both domestically and internationally.
-22 vs industry average
Elite Pharmaceuticals, Inc.’s score of 20 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Elite Pharmaceuticals, Inc. yet.
Elite Pharmaceuticals, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards.
As there are no emissions or reduction initiatives reported, it is unclear how Elite Pharmaceuticals is addressing climate change within its operations. The lack of data may reflect a broader industry context where many companies are still developing their sustainability strategies. Without specific commitments or targets, the company's climate impact remains undefined.
No climate goals have been disclosed for Elite Pharmaceuticals, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more